Nilotinib Hydrochloride from Japan
Nilotinib hydrochloride treats imatinib-resistant chronic myelogenous leukemia. As a pyrimidine derivative with aromatic nitrogen heterocycles, it falls under the 'drugs: other' provision of HTS 2933.99.75.00.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%
Import Tips
• Submit Type II DMF to FDA before import and reference in entry documentation
• Include chiral purity data (S-enantiomer) and heavy metals analysis
• Beware of duty drawback ineligibility if previously exported as finished product